ArticleBehavioural brain research2025
Evaluating alpha-synuclein proteinopathy and consequences for birdsong in zebra finch basal ganglia area X.
Article in Behavioural brain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Lewy body pathology is a major hallmark of Parkinson's Disease (PD) and other dementias. The process of Lewy body formation is largely driven by the aggregation of alpha-synuclein (αsyn), an abundant presynaptic chaperone protein that has been shown to propagate between neurons when misfolded. Preclinical animal models inducing αsyn aggregation in the brain have demonstrated a range of behavioral consequences, though studies connecting behavioral changes to specific features of pathology are lacking. Considering vocal impairment manifests early in individuals with PD and fails to resolve upon dopamine replacement, we examined the effect of αsyn proteinopathy on birdsong in adult male zebra finches to investigate these early mechanisms of PD-related vocal dysfunction. In this study, we describe a novel tool for measuring αsyn expression called the Border Expression Ratio (BER) based on the discrete physiological distribution of αsyn surrounding basal ganglia song center, Area X. Following overexpression of human αsyn in Area X using bilateral injections of adeno-associated virus, we show that BER can be used to measure regional αsyn proteinopathy, revealing a positive correlation between right hemisphere pathology and a reduction in the variation of harmonic syllable duration. Finally, we provide evidence of serine 129 phosphorylation-a biomarker for aggregated αsyn-in Area X and cortical song nucleus LMAN of αsyn-overexpressing finches, despite this residue not being conserved in zebra finch αsyn, indicating modification of the human transgene. Together, these findings provide a framework for future analyses investigating αsyn propagation over time and the effects on vocal behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.